With the ease of lockdown and the reopening of research labs, we spoke to scientists and quality assurance (QA) managers to understand more about their roles, and asked them to share what they are looking forward to and their thoughts on upcoming challenges.
We speak to Sarah Danson of Sheffield ECMC about her background and her vision for the Adult Network Strategy Group in 2020 and beyond.
Aoife Regan gives an update from the summer, discussing about the Phase I: Where Science Becomes Medicine conference, changes in the Programme Office, and her thoughts for the future.
The new Lead of the Birmingham ECMC talks to us about his career to date, the biggest challenges facing clinical research, and the exciting, unpredictable future for immunotherapy.
Gareth Veal discusses his team’s new therapeutic drug monitoring service, aiming to assist in the treatment particularly “hard-to-treat” childhood cancer patients.
Aoife Regan has recently returned from maternity leave back to her position as Head of the ECMC Programme Office. Aoife reflects on what’s changed in the network while she’s been away, what she’s planning to focus on and the challenges to come.
The new Lead of the Manchester ECMC talks to us about her career to date, balancing NHS service and clinical research commitments, precision medicine ... and the Enigma code.
The new Lead of the Southampton ECMC talks to us about his career to date, the biggest challenges facing clinical research and the strengths of the ECMC network.
The newest recruit to the ECMC Programme Office tells us about here career to date and what she is most excited about in her new role.